Consensus Ipsen

Equities

Market Closed - Euronext Paris Other stock markets 11:38:02 2024-04-26 am EDT			5-day change	1st Jan Change
113 ^EUR	+0.62%		+4.24%	+4.73%

Apr. 24	IPSEN : Better-than-expected Q1; guidance unchanged
Apr. 24	Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024

68001827d53.KrVIltrbpS2aowUUA2v1X6RGr3yO-jDzch-xV-pc7Uw.TNN4453i4mnQ9EsmUlOqJugP-Qvakh3FF1rrHN45vChthHnsrr3fFf-aYg~fc07eec3dbfbf19962033e6c44d1b000

IPSEN : Better-than-expected Q1; guidance unchanged	Apr. 24
IPSEN : Ipsen’s underlying fundamentals remain promising	Mar. 13
Deutsche Bank Reduces Ipsen PT, Keeps Hold Rating	Feb. 16	MT
IPSEN : Deutsche Bank cuts its target	Feb. 16	CF
IPSEN : UBS reiterates its buy recommendation	Feb. 14	CF
IPSEN : In line Q4 sales; lower-than-expected 2024 guidance	Feb. 08
IPSEN : Deutsche Bank lowers its target price	Dec. 15	CF
IPSEN : Ipsen outlined some promising mid-term takeaways at the CMD	Dec. 08
IPSEN : UBS remains Buy after CMD	Dec. 08	CF
IPSEN : RBC maintains 'in-line performance' rating	Nov. 29	CF
IPSEN : Jefferies downgrades recommendation to 'hold	Nov. 20	CF
IPSEN : Modest Q3 sales growth; guidance unchanged	23-10-26
Ipsen: upbeat with broker upgrade	23-09-12	CF
UBS Upgrades Ipsen to Buy from Neutral, Boosts PT	23-09-12	MT
IPSEN : UBS raises its recommendation	23-09-12	CF
IPSEN : RBC welcomes Cabometyx data	23-08-21	CF
IPSEN : AlphaValue upgrades its recommendation to 'buy	23-08-08	CF
IPSEN : Deutsche Bank raises its price target	23-08-08	CF
IPSEN : A compelling small Pharma	23-08-07
IPSEN : Healthy Q2 sales + a guidance upgrade	23-07-27
IPSEN : Healthy Q1 sales; full-year guidance maintained	23-04-27
IPSEN : Promising end to 2022	23-04-17
IPSEN : Oddo raises its target price	23-02-13	CF
IPSEN : Promising end to 2022	23-02-09
IPSEN : UBS reiterates its recommendation on the stock	23-01-24	CF